A Phase II Study of Pancreatic Enzyme Replacement (Zenpep) on Completion Rates of Adjuvant Chemotherapy Among Subjects With Resected Pancreatic Ductal Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 11 Mar 2019
Price : $35 *
At a glance
- Drugs Pancrelipase (Primary)
- Indications Exocrine pancreatic insufficiency
- Focus Therapeutic Use
- 06 Mar 2019 Status changed from not yet recruiting to recruiting.
- 02 Apr 2018 Planned initiation date changed from 30 Mar 2018 to 16 Apr 2018.
- 21 Mar 2018 New trial record